NEO
NEOGENOMICS INC
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$16.42
−1.38%Forward multiples
Based on analyst estimates
- P/E forward
- 52.97x
- P/E 2026E
- 88.64x
- P/E 2027E
- 48.43x
- P/E 2028E
- 36.54x
- P/S forward
- 2.44x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.68x
- Price / sales
- 2.75x
- Price / cash flow
- 95.68x
Enterprise value
- Enterprise value
- $2.4B
- EV / sales
- 3.15x
- EV / EBITDA
- 187.21x
- EV / EBIT
- -36.46x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026